Kinesin family member 14 expression and its clinical implications in colorectal cancer

doi:10.4251/wjgo.v17.i3.102696

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (159)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-12) series.

Item

Count

PDF

HTML

Figures (1-12)

Sum=127

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=26

Mar 15, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102696
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102696

Kinesin family member 14 expression and its clinical implications in colorectal cancer

Kai Qin, Jia-Yuan Luo, Da-Tong Zeng, Wan-Ying Huang, Bin Li, Qi Li, Yan-Ting Zhan, Rong-Quan He, Wei-Jian Huang, Gang Chen, Zu-Yuan Chen, Bang-Teng Chi, Yu-Xing Tang, Rui-Xue Tang, Hui Li

Kai Qin, Jia-Yuan Luo, Wan-Ying Huang, Bin Li, Qi Li, Yan-Ting Zhan, Gang Chen, Zu-Yuan Chen, Bang-Teng Chi, Yu-Xing Tang, Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China

Da-Tong Zeng, Wei-Jian Huang, Department of Pathology, Redcross Hospital of Yulin City, Yulin 537000, Guangxi Zhuang Autonomous Region, China

Rong-Quan He, Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China

Rui-Xue Tang, Department of Pathology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250000, Shandong Province, China

Hui Li, Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China

Co-first authors: Kai Qin and Jia-Yuan Luo.

Co-corresponding authors: Rui-Xue Tang and Hui Li.

Author contributions: Qin K, Luo JY, Tang RX and Li H conceived and designed the study; Zeng DT, Huang WY, Li B and Li Q analyzed the data and performed all the graphs; Zhan YT, He RQ, Huang WJ, Chen G, Chen ZY, Chi BT and Tang YX conducted the experiments; Qin K and Luo JY drafted the manuscript; Tang RX and Li H revised the manuscript. The decision for co-first authorship is based on the substantial and equal contributions of Qin K and Luo JY to the conception, design, execution, and interpretation of the research presented in this manuscript. The designation of co-corresponding authors, Tang RX and Li H, is attributed to their shared responsibility in overseeing the submission, revision, and communication aspects of this work with the journal. All authors have played a crucial role in drafting and revising the manuscript and have approved the final version.

Supported by Natural Science Foundation of Shandong Province, No. ZR2020QH185; Scientific Research Nurturing Fund of The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, No. QYPY2020NSFC0803; Guangxi Zhuang Autonomous Region Health Commission Scientific Research Project, No. Z-A20220415; Guangxi Medical University Teacher Teaching Ability Development Project, No. 2022JFA02; and Guangxi Medical University Undergraduate Education and Teaching Reform Project, No. 2023Y05.

Institutional review board statement: The protocol for this research project has been approved by a suitably constituted Ethics Committee of Yulin Red Cross Hospital, Approval No. Z20210442.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: The data was available from the corresponding author at lihui_gxmu@163.com.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Hui Li, Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. lihui_gxmu@163.com

Received: October 28, 2024
Revised: November 22, 2024
Accepted: December 25, 2024
Published online: March 15, 2025
Processing time: 111 Days and 20.1 Hours

Core Tip

Core Tip: This study evaluates the clinical and pathological significance of Kinesin family member 14 (KIF14) in colorectal cancer (CRC) and explores its interaction with nitidine chloride (NC) as a potential therapeutic target. High KIF14 expression in CRC was confirmed through immunohistochemistry and multiplatform mRNA analysis, with significant diagnostic accuracy. Clustered regularly interspaced short palindromic repeats screening and single-cell sequencing validated KIF14’s role in CRC cell growth. Survival analysis highlighted KIF14’s prognostic value. Molecular docking revealed a strong binding affinity between NC and KIF14, suggesting that KIF14 is a promising target for NC in CRC treatment.